Hester Biosciences Limited (NSE:HESTERBIO)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Poultry Healthcare	2.06B	1.67B	1.45B	1.41B	1.72B
Animal Healthcare	1.27B	1.44B	1.33B	1.14B	631.75M
Others	-	-	267.89M	88.69M	-
Petcare	-	-	-	17.67M	-
Total	3.33B	3.11B	3.05B	2.66B	2.35B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	2.62B	2.61B	2.39B	2.17B	1.90B
outside India	706.28M	501.54M	653.76M	491.69M	448.29M
Total	3.33B	3.11B	3.05B	2.66B	2.35B

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error